switching glp 1 Patients without diabetes who switched between glucagon-like peptide-1 receptor agonist (GLP-1RA) medications for overweight or obesity were more likely to remain engaged with treatment than those who stayed on the same medication How to Talk to Your

Presented for research literature review only Davenport CJ et al

For someone using or considering GLP-1s (or wanting to avoid them), supplementing with high-quality, whole-food nutrients can help fill the gaps: ensuring adequate micronutrient intake, supporting GI health, maintaining lean mass, supporting metabolic regulation, and perhaps reducing reliance on medication by optimizing physiology

At Reliable MD, medical weight loss programs and options are provided along with a range of other services

Neuroscience 541:91100 Wu H, Zhang P, Zhou J, Hu S, Hao J, Zhong Z et al (2024) Paeoniflorin confers ferroptosis resistance by regulating the gut microbiota and its metabolites in diabetic cardiomyopathy